Form 10-Q ALNYLAM PHARMACEUTICALS, For: Jun 30

Related Keywords

Ukraine ,Washington ,United States ,University Of Massachusetts ,Massachusetts ,Utah ,Boston ,China ,Brazil ,New York County ,New York ,Canada ,United Kingdom ,Russia ,District Of Columbia ,Delaware ,State Of New York ,University Of Utah ,Switzerland ,Cambridge ,Cambridgeshire ,Cambodia ,Commonwealth Of Massachusetts ,California ,City Of Cambridge ,Japan ,Swiss ,British ,America ,Canadian ,Japanese ,Cambodian ,American ,Max Planck ,Yvonnel Greenstreet ,Zur Foerderung ,Henria Termeer Square ,Maximillian Schrems ,Tolga Tanguler ,Novo Nordisk ,Jeffreyv Poulton ,Silicon Valley Bank ,Blackstone Life Sciences ,Us Department Of Health ,Arbutus Biopharma Corp ,B Drug Pricing Program ,Brazilian Health Regulatory Agency ,European Patent Office ,Human Services ,Us Court ,Securities Exchange ,Corporation Law ,Revenue Service ,Bridgebio Pharma Inc ,Sanofi Company ,Pfizer Inc ,Us Treasury Department ,Family Investment Partnership ,Regeneron Pharmaceuticals Inc ,Blackstone Group Inc ,Research Term ,Peptidream Inc ,Benitec Biopharma Ltd ,Genzyme Corporation ,Committee On Deficit Reduction ,Genevant Sciences ,Us Attorney Office ,Moderna Inc ,Name Of Each Exchange On Which ,Public Health Service ,Vir Biotechnology Inc ,Dicerna Pharmaceuticals Inc ,Allena Pharmaceuticals Inc ,Alnylam Pharmaceuticals Inc ,Department Of Defense ,Stage Clinical Development ,Permanent Representatives Committee Of The Council ,Moderna Us Inc ,Us Export Administration Regulations ,Astrazeneca ,Novartis ,Department Of Health ,Modernatx Inc ,Akcea Therapeutics Inc ,Children Health Insurance Program ,Genentech Inc ,Payments Program ,High Court ,Chester County Employees Retirement Fund ,Nasdaq Stock Market ,Exchange Commission On ,Arrowhead Pharmaceuticals Inc ,Marina Biotech Inc ,Organization For Economic ,Roivant Sciences ,Us Supreme Court ,Drug Administration ,Us District Court ,Us Patent Office ,Medicaid Services ,Pharmacia Upjohn Co ,Centers For Medicare ,Pfizer ,Alnylam United Kingdom Ltd ,Health Information Technology For Economic ,Medicaid Drug Rebate Program ,Life Sciences Ltd ,European Union ,Health Insurance Portability ,Outcomes Research Institute ,Research Term Extension Period ,American Arbitration Association ,National Institutes Of Health ,Supreme Court ,District Court ,Office Of Inspector ,Department Of Veterans Affairs ,Us Department Of Justice ,United States District Court ,Roche Ltd ,Us Department Of Labor ,Merck Sharp Dohme Corp ,Arcturus Therapeutics Inc ,Clinical Health ,First Department ,Renal Drugs Advisory Committee ,Takeda Pharmaceutical Company Ltd ,Incorporation Or Organization ,Regeneron Pharmaceuticals ,Electronic Communications Regulations ,Supreme Court On ,Health Administration ,Commission File Number ,Quark Pharmaceuticals Inc ,Trademark Office ,Medicines Company ,Research Services Obligation ,Exact Name ,Its Charter ,Kendall Street ,Principal Executive Offices ,Zip Code ,Telephone Number ,Including Area Code ,Each Exchange ,Securities Exchange Act ,Interactive Data File ,Regulations T ,Exchange Act ,Common Stock ,Alnylam Act ,Alnylam Pharmaceuticals ,Quarterly Report ,Securities Act ,Private Securities Litigation Reform Act ,Months Ended June ,Annual Report ,Exchange Commission ,Consolidated Financial Statements ,Accounting Standards Codification ,Collaborative Arrangements ,Regeneron Collaboration ,Master Agreement ,Regeneron Master Agreement ,Initial Research ,Initial Research Term ,Novartis License Agreement ,Purchase Agreement ,Blackstone Royalties ,Royalty Interest ,Purchased Interest ,Cash Equivalents ,Senior Notes Due ,Convertible Senior Notes ,Additional Notes ,Initial Notes ,Capped Call ,Capped Call Transactions ,Funding Agreement ,Blackstone Life Science ,Life Sciences ,License Agreement ,Roche Collaboration ,Strategic Therapeutic Areas ,Cardio Metabolic Diseases ,Hepatic Infectious Diseases ,Genetic Medicines ,United States Food ,New Drug Application ,Prescription Drug User Fee Act ,Business Conduct ,Vir Biotechnology ,Dicerna Pharmaceuticals ,Ocular Disease ,Hepatic Infectious Disease ,Genetic Medicine ,Exclusive License Agreement ,License Terms ,Peptide Discovery Platform System ,Accounting Policies ,Financial Condition ,Condensed Consolidated Financial ,Chief Executive Officer ,Chief Financial Officer ,Related Risks ,Risks Related ,Managing Our ,Latin America ,Clinical Testing ,Regulatory Approval ,Product Candidates ,Convertible Notes ,Financial Results ,Internal Revenue Service ,Economic Co Operation ,North American ,Investigational New Drug ,Risk Evaluation ,Mitigation Strategy ,Anti Kickback Statute ,False Claims Act ,Executive Order ,Indian Tribes ,Medicare Prescription Drug ,Modernization Act ,Most Favored Nation ,Interim Final Rule ,Average Manufacturer Price ,Best Price ,Pharmaceutical Research ,Patient Protection ,Affordable Care Act ,Drug Pricing Program ,Public Health Service Act ,Veterans Affairs ,Patient Centered Outcomes Research Institute ,Medicaid Innovation ,Budget Control Act ,Joint Select Committee ,Deficit Reduction ,American Taxpayer Relief Act ,Columbia Circuit ,Rehearing En Banc ,Inflation Reduction Act ,Stargardt Disease ,President Biden ,Administration Regulations ,Foreign Assets Control ,Foreign Corrupt Practices Act ,Member States ,Accountability Act ,Health Information Technology ,Clinical Health Act ,Health Insurance Program ,Open Payments Program ,Federal Government ,General Data Protection Regulation ,Privacy Directive ,California Consumer Privacy Act ,California Privacy Rights Act ,Inspector General ,Risk Factor ,United Kingdom U ,Data Protection Commissioner ,Facebook Ireland ,Privacy Shield ,Standard Contractual Clauses ,European Data Protection Board ,International Data Transfer Agreement ,International Data Transfer Addendum ,Atlantic Data Privacy ,Privacy Framework ,United Kingdom Government ,Data Protection ,Digital Information Bill ,United Kingdom Bill ,Privacy Regulation ,Permanent Representatives Committee ,Bipartisan Budget Act ,National Institutes ,Occupational Safety ,United States Patent ,America Invents Act ,Silence Therapeutics ,Alnylam United Kingdom ,Max Planck Innovation ,Merck Sharp ,Dohme Corp ,Sherman Antitrust ,Bridgebio Pharma ,Allena Pharmaceuticals ,Breakthrough Therapy Designation ,Marina Biotech ,Quark Pharmaceuticals ,Sciences Ltd ,Silicon Valley ,New York State Securities Litigation ,Delaware General Corporation Law ,Capped Calls ,Option Counterparties ,Option Counterparty ,Financial Accounting Standards Board ,Accounting Standards Update ,Chief Commercial Officer ,Commercial Officer ,Principal Executive Officer ,Vice President ,Chief Financial ,Principal Financial ,Accounting Officer ,